Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M4BI
|
|||
Drug Name |
Benzamide derivative 1
|
|||
Synonyms |
PMID28051882-Compound-18
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Washington University
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H31BrN2O5
|
|||
Canonical SMILES |
COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br
|
|||
InChI |
1S/C24H31BrN2O5/c1-29-20-11-16-7-10-27(15-17(16)12-21(20)30-2)9-6-5-8-26-24(28)19-13-18(25)14-22(31-3)23(19)32-4/h11-14H,5-10,15H2,1-4H3,(H,26,28)/i25-4
|
|||
InChIKey |
UNYNHWPKQAKANT-VEFBWTBNSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.